Success requires personal commitment, lifestyle changes, and consistent medical support
Semaglutide seems to have a slight edge in reducing the risk of side effects, based on studies that assessed the risk of GI upset and pancreatitis.2 10 In our conversations with diabetic GLP-1 RA users, weve found that doctors will often start patients out on Ozempic, which uses the same active ingredient as Wegovy (semaglutide), as opposed to a drug based on tirzepatide
Tri-Immunity Injection: Boosts immune function and aids in quicker recovery from illness
remain flexible and willing to adjust
Purpose-built for physicians GLP-1 use before weight-loss surgery rising, not linked to harmful outcomes Key takeaways: The use of GLP-1 receptor agonists in the year before weight-loss surgery rose more than threefold between 2018 and 2023
In younger patients, this is manageable with adequate protein intake and resistance exercise